Menière's disease: combined pharmacotherapy with betahistine and the MAO-B inhibitor selegiline-an observational study.

Strupp M, Kraus L, Schautzer F, Rujescu D

DOI: 10.1007/s00415-018-8809-8
Published: 2018 Oct
Container: Journal of neurology
Publisher: Not recorded
Open access: unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s00415-018-8809-8,
  title = {Menière's disease: combined pharmacotherapy with betahistine and the MAO-B inhibitor selegiline-an observational study.},
  author = {Strupp M and Kraus L and Schautzer F and Rujescu D},
  year = {2018},
  journal = {Journal of neurology},
  doi = {10.1007/s00415-018-8809-8},
  url = {https://doi.org/10.1007/s00415-018-8809-8}
}

RIS

TY  - JOUR
TI  - Menière's disease: combined pharmacotherapy with betahistine and the MAO-B inhibitor selegiline-an observational study.
AU  - Strupp M
AU  - Kraus L
AU  - Schautzer F
AU  - Rujescu D
PY  - 2018
JO  - Journal of neurology
DO  - 10.1007/s00415-018-8809-8
UR  - https://doi.org/10.1007/s00415-018-8809-8
ER  -

APA

M, S., L, K., F, S., & D, R. (2018). Menière's disease: combined pharmacotherapy with betahistine and the MAO-B inhibitor selegiline-an observational study.. Journal of neurology. https://doi.org/10.1007/s00415-018-8809-8

Source records

pubmed · retrieved 2026-09-24T19:54:12.957Z